Yılmaz V - Search Results

1

Classical complement pathway factor alterations in narcolepsy.

Yüceer H, Gezen Ak D, Benbir Şenel G, Dursun E, Yılmaz V, Karadeniz D, Tüzün E, Küçükali Cİ. Yüceer H, et al. Among authors: yilmaz v. Acta Neuropsychiatr. 2022 Aug;34(4):212-219. doi: 10.1017/neu.2021.42. Epub 2022 Jan 17. Acta Neuropsychiatr. 2022. PMID: 35034679

2

Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis.

Li J, Qi H, Tüzün E, Allman W, Yilmaz V, Saini SS, Deymeer F, Saruhan-Direskeneli G, Christadoss P. Li J, et al. Among authors: yilmaz v. J Neuroimmunol. 2009 Mar 31;208(1-2):40-5. doi: 10.1016/j.jneuroim.2008.12.013. Epub 2009 Feb 3. J Neuroimmunol. 2009. PMID: 19193448

3

Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients.

Tüzün E, Yılmaz V, Parman Y, Oflazer P, Deymeer F, Saruhan-Direskeneli G. Tüzün E, et al. Among authors: yilmaz v. Med Princ Pract. 2011;20(6):581-3. doi: 10.1159/000330031. Epub 2011 Oct 4. Med Princ Pract. 2011. PMID: 21986021 Free article.

4

Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice.

Ulusoy C, Kim E, Tüzün E, Huda R, Yılmaz V, Poulas K, Trakas N, Skriapa L, Niarchos A, Strait RT, Finkelman FD, Turan S, Zisimopoulou P, Tzartos S, Saruhan-Direskeneli G, Christadoss P. Ulusoy C, et al. Among authors: yilmaz v. Clin Immunol. 2014 Apr;151(2):155-63. doi: 10.1016/j.clim.2014.02.012. Epub 2014 Feb 28. Clin Immunol. 2014. PMID: 24589747

5

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.

Yilmaz V, Oflazer P, Aysal F, Durmus H, Poulas K, Yentur SP, Gulsen-Parman Y, Tzartos S, Marx A, Tuzun E, Deymeer F, Saruhan-Direskeneli G. Yilmaz V, et al. PLoS One. 2015 Apr 20;10(4):e0123546. doi: 10.1371/journal.pone.0123546. eCollection 2015. PLoS One. 2015. PMID: 25893403 Free PMC article.

6

Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder.

Tokac D, Tuzun E, Gulec H, Yılmaz V, Bireller ES, Cakmakoglu B, Kucukali CI. Tokac D, et al. Among authors: yilmaz v. Psychiatry Investig. 2016 Sep;13(5):541-548. doi: 10.4306/pi.2016.13.5.541. Epub 2016 Sep 30. Psychiatry Investig. 2016. PMID: 27757133 Free PMC article.

7

Viability of SH-SY5Y cells is associated with purinergic P2 receptor expression alterations.

Örçen A, Yilmaz V, Giriş M, Akcan U, Tüzün E, Erten G. Örçen A, et al. Among authors: yilmaz v. Acta Biol Hung. 2017 Mar;68(1):22-34. doi: 10.1556/018.68.2017.1.3. Acta Biol Hung. 2017. PMID: 28322086 Free article.

8

Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.

Ulusoy C, Çavuş F, Yılmaz V, Tüzün E. Ulusoy C, et al. Among authors: yilmaz v. Immunol Invest. 2017 Jul;46(5):490-499. doi: 10.1080/08820139.2017.1299754. Epub 2017 Apr 4. Immunol Invest. 2017. PMID: 28375749

9

Peripheral blood memory B cell frequency predicts conversion from clinically isolated syndrome to multiple sclerosis.

Aktura ŞD, Yılmaz V, Özkan-Yaşargün D, Ulusoy C, Tüzün E, Türkoğlu R. Aktura ŞD, et al. Among authors: yilmaz v. Mult Scler Relat Disord. 2018 Jul;23:9-14. doi: 10.1016/j.msard.2018.04.015. Epub 2018 Apr 24. Mult Scler Relat Disord. 2018. PMID: 29709798

10

Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis.

Gencer M, Akbayır E, Şen M, Arsoy E, Yılmaz V, Bulut N, Tüzün E, Türkoğlu R. Gencer M, et al. Among authors: yilmaz v. Neurol Sci. 2019 May;40(5):1067-1070. doi: 10.1007/s10072-019-3708-z. Epub 2019 Jan 15. Neurol Sci. 2019. PMID: 30645749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

289 results

Search Page